Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0X8ED
|
|||
| Former ID |
DNC000294
|
|||
| Drug Name |
Benserazide
|
|||
| Synonyms |
benserazide; Serazide; 322-35-0; Benseraszide; Benserazida; Benserazidum; Ro 4-4602; Ro 44602; DL-Serine 2-(2,3,4-trihydroxybenzyl)hydrazide; Benserazidum [INN-Latin]; Benserazida [INN-Spanish]; Benserazide [USAN:INN:BAN]; DL-Seryltrihydroxybenzylhydrazine; C10H15N3O5; BRN 3984490; DL-Serine, 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide; CHEBI:64187; DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide; Serine, 2-(2,3,4-trihydroxybenzyl)hyrazide, DL-; DL-serine 2-[(2,3,4-trihydroxyphenyl)methyl]hydrazide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H15N3O5
|
|||
| Canonical SMILES |
C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O
|
|||
| InChI |
1S/C10H15N3O5/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16/h1-2,6,12,14-17H,3-4,11H2,(H,13,18)
|
|||
| InChIKey |
BNQDCRGUHNALGH-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 322-35-0
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
4377832, 7978766, 8151557, 11335644, 11360883, 11362884, 11365446, 11368008, 11371504, 11373793, 11376170, 11461855, 11466966, 11468086, 11483956, 11486781, 11487956, 11490128, 11492062, 11493884, 15094804, 17397237, 29221497, 47365134, 47662229, 47736422, 47810707, 48035061, 48035062, 48184949, 48259180, 48415611, 49698844, 50045961, 50105250, 51050847, 57321254, 87218954, 90341370, 92308983, 92711322, 92729799, 103752630, 104300267, 116933600, 124749559, 124879445, 124879446, 125536869, 126630978
|
|||
| ChEBI ID |
CHEBI:64187
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Catechol-O-methyltransferase inhibitors in the management of Parkinson's disease. Semin Neurol. 2001;21(1):15-22. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.